P2RY12 and Patent foramen ovale: The pooled analysis of the enrolled studies showed that P2Y12 inhibitor responders had an almost parallel MHA response to subsequent PFO closure after discontinuing the medication, suggesting that at least in these responsive populations, the right to left passage of venous platelet activation or aggregation acts as a main MHA mechanism/trigger.